Prognostic indicators of 6-month mortality in elderly people with advanced dementia: A systematic review
- Anna M Barron, Department of Biophysics and Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan. Email: barron.anna@graduate.uwa.edu.au
Abstract
Background: For
end-of-life dementia patients, palliative care offers a better quality
of life than continued aggressive or burdensome
medical interventions. To provide the best care
options to dementia sufferers, validated, reliable, sensitive, and
accurate
prognostic tools to identify end-of-life
dementia stages are necessary.
Aim: To identify
accurate prognosticators of mortality in elderly advanced dementia
patients consistently reported in the literature.
Design: Systematic literature review.
Data sources: PubMed,
Embase, and PsycINFO databases were searched up to September 2012.
Reference lists of included studies were also
searched. Inclusion criteria were studies
measuring factors specifically related to 6-month outcome in patients
diagnosed
with dementia in any residential or health-care
setting.
Results: Seven studies
met the inclusion criteria, five of which were set in the United States
and two in Israel. Methodology and
prognostic outcomes varied greatly between the
studies. All but one study found that Functional Assessment Staging
phase 7c,
currently widely used to assess hospice
admission eligibility in the United States, was not a reliable predictor
of 6-month
mortality. The most common prognostic variables
identified related to nutrition/nourishment, or eating habits, followed
by
increased risk on dementia severity scales and
comorbidities.
Conclusions: Although
the majority of studies agreed that the Functional Assessment Staging 7c
criterion was not a reliable predictor
of 6-month mortality, we found a lack of
prognosticator concordance across the literature.
Further studies are
essential to
identify reliable, sensitive, and specific
prognosticators, which can be applied to the clinical setting and allow
increased
availability of palliative care to dementia
patients.
This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original
work is attributed as specified on the SAGE and Open Access page(http://www.uk.sagepub.com/aboutus/openaccess.htm).
No comments:
Post a Comment